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Abstract
Introduction Surgical management of skin cancer is an
important part of modern maxillofacial surgery. The
common tumours treated are squamous cell carcinoma,
malignant melanoma and some benign lesions, but the
largest group of tumours are the basal cell carcinomas.
Although only locally aggressive, if they are not com-
pletely removed, recurrence may occur and be trouble-
some, especially in the head and neck. Even in this
region, incomplete excision is uncommon, less than
20 %, but management of positive margins remains
controversial. This review evaluates the effectiveness of a
further surgical intervention after a positive margin.
Materials and methods A retrospective audit was under-
taken to determine the rate of positive margins within
the unit and subsequently the percentage of residual
tumour found in any secondary excisions.
Results The results show that in a sample of 247
patients, 11 % had positive peripheral margins. A sec-
ond excision only showed that 36 % had any evidence
of residual tumour.
Discussion The study raises the question of the value of
further surgery. Finally, the authors suggest a more
focused approach to the finding of a positive margin
before the patient is offered more treatment.
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Introduction
Basal cell carcinoma (BCC) is a very common skin tumour
which is usually slow-growing and benign in nature, with
metastasis being exceptionally rare. A variety of treatment
methods have been described: surgery, radiotherapy and
chemotherapy, used topically or in conjunction with photo-
dynamic therapy, curettage and cryosurgery. The type of
treatment should be based on the patient's medical history,
type, size and site of the tumour, but may also depend on the
experience of the clinician who first assesses the patient.
For those patients who are treated by surgical excision,
very high success rates, in terms of elimination of the
tumour, should be expected. The British Association of
Dermatologists (BAD) estimate that if the tumour were
removed with a clinical margin of 3 mm, it would be
expected that, microscopically, the tumour would be ade-
quately excised in 85 % of cases [1]. Other histopathological
factors may mitigate against successful removal. For exam-
ple, an aggressive lesion with perineural spread may pro-
duce skip lesions outside the excision margins. For certain
types of BCC, such as morphoeic, infiltrative or multifocal
lesions, the peripheral margins, and therefore positive mar-
gins, are more difficult to identify, so the risk of recurrence
is more likely. In such difficult cases, Mohs dermographic
surgery, an interactive histological checking of the margins,
may be required.
Material and method
Organisation of the service
The maxillofacial unit is part of the team managing skin
cancer. The local team consists of dermatologists, surgeons,
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pathologists and support nurses. This team integrates into a
regional cancer team with other units and additionally
includes oncologists and radiotherapists. BCCs would not
normally be discussed at the regional team level. Since it has
been reported that the diagnostic success of dermatologists
is much greater than non-dermatologists, the dermatologist
sees all patients first, and the surgical cases are referred on to
the surgeons, the majority going to maxillofacial surgery.
Organisation of the study
In this study, we looked at all cases of skin cancer removed
by maxillofacial surgery for the period of January–Decem-
ber 2009 undertaken by one surgeon. During this time, not
all the cases were sent to the same histopathology laborato-
ry, and so the study was reduced to include only those sent
to the Surrey & Sussex Histopathology Department, and
which were histologically proven to be BCCs.
The patients were identified from the database by the
surgeon's name and then by the histopathological diag-
nosis BCC. The pathology reports were then reviewed
retrospectively.
Of the 792 patients operated on by the surgeon, only
247 BCCs were studied. These cases were only selected
on the basis that the histopathological examination was
carried out at the Surrey & Sussex Pathology Depart-
ment. There was no clinical bias, which would affect
the referral to this department. All the surgery was
undertaken by one surgeon, regardless of where the
histology was finally reviewed.
Results
The total positive-margin rate for the 792 patients was 10 %,
but of the 247 patients in the study, it was 11 %. Table 1
summarises the results. Of the 247 cases which were iden-
tified for inclusion in the audit, 232 excisions were from the
head and neck region, 11 from the limbs and 4 from the
trunk. In total, 29 (11.7 %) had positive margins, and 96 %
of these were found on the head and neck (11 % of all
specimens).
Figure 1 shows the percentage of lateral margins found to
be involved compared to deep margins. In the majority of
cases, the lateral margin was involved.
The main type of BCC (Fig. 2) found in the positive-
margin group was nodular, followed by nodular infiltrative;
in a small number of cases, morphoeic and basosquamous
types were found. As the specimen type was not recorded in
all cases, it is difficult to determine whether this is a signif-
icant factor or not.
Figure 3 shows the location, by percentage, of all speci-
mens with positive histological margins. The forehead and
cheek account for almost half of specimens with positive
margins.
Of the 29 margin positive excisions, 22 underwent fur-
ther surgery at a later date and eight (36 %) of these sec-
ondary excisions contained residual tumour. Of the seven
patients who chose not to undergo further surgery, three
have been lost to follow up and four show no evidence of
recurrence 18(+) months post primary excision.
Discussion
These results show that the positive-margin rate is within the
expected range of published data. Studies from current
literature suggest rates of positive margins ranging from 4
to 16.6 % [2–7]. The BAD recommendation suggests that a
3-mm margin of excision will give an 85 % “clear” margin
rate [1]. These figures are above that at 11.7 % positive-
margin rate. It is interesting to note the slightly different
rates seen in the two samples, the overall cases in 2009
(10 %) and the 247 (11.7 %) cases examined at Surrey &
Sussex Pathology Department. This is most likely due to the
size of the sample rather than any local variation.
The numbers of cases with positive margins is, as
expected, small. It is therefore difficult to draw conclusions
















Head and neck 232 94 28 11 96
Trunk 4 2 1 0.7 4
Limbs 11 4 0 – –
Total 247 100 29 11.7 100
Fig. 1 Percentage of lateral vs. deep margins
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as to the cause of the positive margin. In this group, it did
not appear to be related to site nor BCC type, but the
numbers are too small for any statistical analysis. The liter-
ature, however, suggests that head and neck cases have a
higher positive-margin rate, as does the canthal area within
the head and neck [2, 3, 5]. It is assumed that this is due to
the difficulty in removing a relatively benign tumour with-
out wishing to damage important anatomical structures.
Similarly, the literature suggests greater difficulty in com-
plete removal of BCCs of certain clinical types, morphoeic,
infiltrative and multi-focal [2]. This reflects the difficulty of
clinically identifying the margin and the diffuse spreading
nature of these lesions. Again, this study showed none of
these issues to be important.
In addition, the study confirms the impression that re-
operating, even soon after the primary surgery, will produce
very few cases where tumour still remains visible, with
64 % being tumour-free. This could be explained by caution
on the behalf of the histologists to call a positive margin
when in reality it was a close margin. Some have suggested
that the surgery stimulates the immune system to eliminate
the remaining tumour cells, an event not seen in other
tumours, but theoretically possible [8].
With regards to secondary excisions, the BAD guidelines
[1] suggest that residual tumour is present in 45–54 % of
specimens, whilst other current literature reports a range of
28–54 %. Our figure of 36 % falls within this range [2–7].
Whatever the reason, as surgeons, we need to be able to
advise our patients as to the most likely outcome of further
surgery. For some patients, who understand the tumour to be
benign in its behaviour, justifying the prospect of further
surgery is hard as they will be informed that the likely
outcome is that there will be no tumour present at the second
operation. Other patients, however, will not want the anxiety
of possible recurrence.
A more logical approach in view of these findings might
be as follows:
& Review the histology, in particular
– Is the margin “positive” or “close”?
– Is the deep margin clear?
– Is it histologically an aggressive lesion?
– Are the anatomical site, and the positive-margin site,
important enough to be considered “high risk”? For
example, positive against the medial canthal ligament.
The surgeon could, thus, give the patient more useful
information. For example, with a peripheral margin, which
is close on the temple with no evidence of perineural spread
and the patient understands the situation, it may be worth
asking the patient and his family doctor to watch the area.
Alternatively, for an aggressive lesion which is large and in
the medial canthal area, it would be more appropriate to
advise the patient that more treatment is indicated.
Another raft of treatment options, to those patients with
positive margins, is of course, also available. For example,
radiotherapymay be considered; this is obviously unsatisfactory
in some sensitive areas particularly close to the eye, where there
is a risk of dry eye or cataract formation, but should be consid-
ered, although it does, of course, have the disadvantage of not
providing an update of the histology. Other treatments used for
primary treatment may also be considered, but like these alter-
native treatments, since they were not considered to be appro-
priate initially, these reservations presumably still remain.
It has been suggested that, for those types of BCC which
have been shown to be more at risk of recurrence, or indeed a
positive margin, it may be appropriate to consider the use of
Mohs micrographic surgery in the first instance. The difficulty
can sometimes be a case selection for this type of surgery in
the primary instance as there was no significant difference
found in positive-margin rates between sub-types of BCC in
this study. An interesting randomised control trial found that
there was no significant difference in recurrence of primary
facial basal cell carcinoma between conventional surgical
excision and Mohs surgery, but for recurrent facial BCC,
treatment via Mohs surgery resulted in significantly fewer
Fig. 2 Types of BCC found in primary excisions with histologically
positive margins
Fig. 3 Chart showing sites of origin for positive-margin specimens
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recurrences [9]. One other factor to consider when performing
Mohs surgery is the time factor—as each case can take 2 h to
complete and therefore has a much more limited use.
The previously mentioned limitations of this study lie in
the retrospective nature of the audit, and it would be inter-
esting to conduct a more prospective analysis, ideally a
randomised controlled trial to gain results which may show
more statistical significance.
Conclusion
This review shows the positive-margin rate to be within the
expected range for head and neck BCCs. The study, how-
ever, shows a very low presence of tumour in the second
resection, questioning the value of further surgery. The
authors therefore advocate a more focused approach before
offering the patients more surgery. There should be more
determination to ensure that it is a positive margin and not a
close margin. If the histological features of the lesion are
benign and the anatomical site is not a high-risk site, then a
wait-and-watch approach may be more justified.
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